This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ostberg, J. E. Articles by Conway, G. S. Search for Related Content PubMed PubMed Citation Articles by Ostberg, J. E. Articles by Conway, G. S. Related Collections Cardiovascular Endocrinology Female Endocrinology Obesity

Adipokine Dysregulation in Turner Syndrome: Comparison of Circulating Interleukin-6 and Leptin Concentrations with Measures of Adiposity and C-Reactive Protein

Department of Endocrinology, University College London Hospitals (J.E.O., G.S.C.), London W1T 3AA, United Kingdom; and Adipokines and Metabolism Research Group, Center for Clinical Pharmacology, Department of Medicine, University College London (M.J.H.A., V.M.-A.), London WC1E 6JJ, United Kingdom

Address all correspondence and requests for reprints to: Dr. Gerard S. Conway, Department of Endocrinology, Middlesex Hospital, Mortimer Street, London W1T 3AA, United Kingdom. E-mail: g.conway{at}ucl.ac.uk.

Women with Turner syndrome (TS) have increased risks of atherosclerosis, diabetes mellitus, and obesity. We hypothesized that women with TS have adverse metabolic or inflammatory markers for cardiovascular disease compared with normal women and estrogen-deficient controls. This was a cross-sectional study conducted at University College London Hospitals, UK. One hundred seventeen estrogen-treated women with TS and normal fasting blood glucose were compared with 30 age-matched normal controls and 31 estrogen-treated women with 46,XX premature ovarian failure (POF). The main outcome measures were markers of the metabolic syndrome, including the adipokines IL-6 and leptin, and C-reactive protein (CRP). TS women were more obese than controls (waist circumference, 79.9 ± 12.4, 73.5 ± 6.9, and 74.7 ± 8.6 cm in TS, normal subjects, and POF controls, respectively; P = 0.005; body mass index, 26.8 ± 5.8, 23.7 ± 3.2, and 22.9 ± 3.4 kg/m²; P < 0.001). This obesity was associated with increased CRP (2.9 ± 1.5, 0.8 ± 1.0, and 1.2 ± 0.9 mg/liter; P < 0.001) and IL-6 concentrations (1.5 ± 0.7, 1.0 ± 1.5, and 1.2 ± 0.5 pg/ml; P = 0.014), but lower fasting serum insulin (4.7 ± 2.3, 6.3 ± 3.0, and 6.9 ± 2.9 mIU/ml; P = 0.004), glucose (83 ± 11, 90 ± 7, and 90 ± 7 mg/dl; P < 0.001), and leptin (10.2 ± 6.3, 14.4 ± 7.6, and 14.8 ± 8.1 ng/ml; P = 0.048). Triglyceride concentrations were similar in TS and POF women and were greater than in normal controls (97 ± 53, 97 ± 53, and 71 ± 27 mg/dl; P = 0.024). We conclude that women with TS have various physical and biochemical features suggestive of the metabolic/insulin resistance syndrome, but there is a discrepancy among CRP, IL-6, and leptin, with leptin and fasting insulin concentrations being lower than expected for the degree of obesity. Obesity and estrogen therapy do not fully explain these findings. Women with TS may have specific metabolic defects contributing to cardiovascular risk.

This article has been cited by other articles:

				V. K. Bakalov, C. Cheng, J. Zhou, and C. A. Bondy X-Chromosome Gene Dosage and the Risk of Diabetes in Turner Syndrome J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3289 - 3296. [Abstract] [Full Text] [PDF]

				C. H. Gravholt, B. E. Hjerrild, L. Mosekilde, T. K. Hansen, L. M. Rasmussen, J. Frystyk, A. Flyvbjerg, and J. S. Christiansen Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur. J. Endocrinol., October 1, 2006; 155(4): 583 - 592. [Abstract] [Full Text] [PDF]